Giant cell tumour of bone (GCTB) treatment changed since the introduction of denosumab from purely surgical towards a multidisciplinary approach, with recent concerns of higher recurrence rates after denosumab. We evaluated oncological, surgical, and functional outcomes for distal radius GCTB, with a critically appraised systematic literature review.
Surgical challenges, novel techniques, and systemic treatment of giant cell tumour of bone of the distal radius : clinical outcomes and systematic review of the literature / van der Heijden, L., Bindt, S., Scorianz, M., Ng, C., Gibbons, M.C.L.H., van de Sande, M.A.J., Campanacci, D.A.. - In: BONE & JOINT OPEN. - ISSN 2633-1462. - STAMPA. - 3:(2022), pp. 515-528. [10.1302/2633-1462.37.BJO-2022-0064.R1]
Surgical challenges, novel techniques, and systemic treatment of giant cell tumour of bone of the distal radius : clinical outcomes and systematic review of the literature
Scorianz, Maurizio;Campanacci, Domenico A
2022
Abstract
Giant cell tumour of bone (GCTB) treatment changed since the introduction of denosumab from purely surgical towards a multidisciplinary approach, with recent concerns of higher recurrence rates after denosumab. We evaluated oncological, surgical, and functional outcomes for distal radius GCTB, with a critically appraised systematic literature review.
| File | Dimensione | Formato | |
|---|---|---|---|
|
GCT distal radius 2022.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
1.03 MB
Formato
Adobe PDF
|
1.03 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
